Article info

Protocol
Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review

Authors

  • Haisheng Chen Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Jing Shi Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Wenna Shi Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Hengwei Xu Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Cunxian Duan Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Qing Fan Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Yanhong Wang Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  • Hui Li Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China PubMed articlesGoogle scholar articles
  1. Correspondence to Hui Li; 874223972{at}qq.com
View Full Text

Citation

Chen H, Shi J, Shi W, et al
Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review

Publication history

  • Received June 17, 2020
  • Revised September 24, 2020
  • Accepted October 23, 2020
  • First published November 10, 2020.
Online issue publication 
November 10, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.